BCL9 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.903800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.382400E-01
Normal-vs-Stage2
8.220400E-01
Normal-vs-Stage3
4.531200E-01
Normal-vs-Stage4
1.281780E-01
Stage1-vs-Stage2
1.123170E-01
Stage1-vs-Stage3
4.911600E-02
Stage1-vs-Stage4
8.453000E-01
Stage2-vs-Stage3
1.193430E-01
Stage2-vs-Stage4
2.081700E-03
Stage3-vs-Stage4
1.087820E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.025000E-01
Normal-vs-AfricanAmerican
5.463200E-01
Normal-vs-Asian
9.262800E-01
Caucasian-vs-AfricanAmerican
5.610400E-02
Caucasian-vs-Asian
5.849600E-01
AfricanAmerican-vs-Asian
1.255020E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.217600E-01
Normal-vs-Female
7.780600E-01
Male-vs-Female
3.565600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.557800E-01
Normal-vs-Age(41-60Yrs)
5.110000E-01
Normal-vs-Age(61-80Yrs)
7.759400E-01
Normal-vs-Age(81-100Yrs)
9.790200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.814400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.047200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.574200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.373600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.343200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.150000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.878400E-01
Normal-vs-Daily Drinker
8.996000E-01
Normal-vs-Weekly Drinker
6.251200E-01
Normal-vs-Occasional Drinker
3.500400E-01
Normal-vs-Social Drinker
5.090000E-01
Non Drinker-vs-Daily Drinker
9.848200E-01
Non Drinker-vs-Weekly Drinker
1.651190E-01
Non Drinker-vs-Occasional Drinker
1.323510E-02
Non Drinker-vs-Social Drinker
7.156500E-02
Daily Drinker-vs-Weekly Drinker
2.312000E-01
Daily Drinker-vs-Occasional Drinker
3.245700E-02
Daily Drinker-vs-Social Drinker
1.204430E-01
Weekly Drinker-vs-Occasional Drinker
4.365000E-01
Weekly Drinker-vs-Social Drinker
7.607600E-01
Occasional Drinker-vs-Social Drinker
6.398400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.791900E-02
Normal-vs-Grade 2
3.180700E-03
Normal-vs-Grade 3
5.996200E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.173600E-01
Grade 1-vs-Grade 3
8.285600E-01
Grade 1-vs-Grade 4
5.791900E-02
Grade 2-vs-Grade 3
1.701630E-01
Grade 2-vs-Grade 4
3.180700E-03
Grade 3-vs-Grade 4
5.996200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.233000E-01
Normal-vs-NonDiabetic
6.389400E-01
Diabetic-vs-NonDiabetic
7.203900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.895200E-01
Normal-vs-NoPancreatitis
7.529200E-01
Pancreatitis-vs-NoPancreatitis
9.616200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.357600E-01
Normal-vs-N1
8.442000E-01
N0-vs-N1
7.090100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.667000E-01
Normal-vs-TP53-NonMutant
4.294200E-01
TP53-Mutant-vs-TP53-NonMutant
8.326200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
